Skip to main content

UNITED WE CURE.

We’re Changing How Science Is Done Because Kids Can’t Wait

CBTN doesn’t wait for change—we drive it, turning global collaboration into faster discovery and better futures for children.

RESEARCH COMMUNITYFAMILIES & FOUNDATIONS

UNITED WE CURE.

We’re Changing How Science Is Done Because Kids Can’t Wait

CBTN doesn’t wait for change—we drive it. Through a global network of scientists, clinicians, and advocates, we accelerate discovery, dismantle barriers, and deliver better outcomes, because every child deserves a future filled with possibility.

RESEARCH COMMUNITYFAMILIES & FOUNDATIONS

MAKING THE IMPOSSIBLE POSSIBLE

Powered by the world’s most extensive collection of pediatric brain tumor biosamples, medical data, imaging, and preclinical models, CBTN breaks down research barriers and fuels global collaboration. With research hospitals contributing from every corner of the world and passionate family foundations standing behind our mission, we accelerate the discoveries that will change everything for children.

8,000

patient & family participants

9

countries represented

35

member institutions

24

family foundations

85,000

biosamples

1,000

investigators

442+

research projects

220+

scientific publications

CBTN Curated | HGG-DMG Opens New Data Access to Aggressive Pediatric Brain Tumor

CBTN Curated | HGG-DMG Opens New Data Access to Aggressive Pediatric Brain Tumor

For children diagnosed with aggressive brain tumors, research time matters. Pediatric high-grade gliomas (HGG), including diffuse midline gliomas (DMG), remain among the most difficult childhood brain tumors to study and treat. These tumors are fast-moving, devastating, and urgently in need of new research paths. Yet for many researchers, the first…
Read More
Tracking Tumor Evolution to Advance Pediatric Brain Tumor Research

Tracking Tumor Evolution to Advance Pediatric Brain Tumor Research

For years, pediatric brain tumor research has largely relied on snapshots. A tissue sample collected during surgery. A scan captured at diagnosis. Molecular data tied to a single moment in time. But tumors change. As pediatric brain tumors respond to treatment, recur, or progress, their biology changes over time, yet…
Read More
CBTN Curated | LGG-BRAF Brings Research-Ready Precision to Pediatric Cancer Discovery

CBTN Curated | LGG-BRAF Brings Research-Ready Precision to Pediatric Cancer Discovery

Pediatric brain tumor research depends on seeing more than one piece of the story at a time. A tumor’s molecular profile matters, for example.  So do diagnosis, treatment history, imaging, biospecimen information, and clinical outcomes. But too often, those details live in separate systems, formats, and workflows. That fragmentation limits…
Read More